Doctor Byung Ho Lee

Korea Research Institute of Chemical Technology, Daejeon (Korea (Republic of))

Follow

Contributor content

Preventive effects of novel urotensin II receptor antagonist in experimental pulmonary arterial hypertension

Presentation

Preventive effects of novel urotensin II receptor antagonist in experimental pulmonary arterial hypertension

ESC 365 is supported by

novartis

Explore sponsored resources